MedTrace Logo

The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS

NCT03808402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2973

Last updated 2025-05-31

No results posted yet for this study

Summary

A prospective observational study using de-identified data from the Neonatal Network Research Database (NNRD) supplemented by additional information on dose, method of surfactant administration and dosing frequency to assess whether the dose and method of administration of surfactant given to preterm infants with respiratory distress syndrome (RDS) affects neonatal outcomes.

Conditions

  • Respiratory Distress Syndrome
  • Bronchopulmonary Dysplasia

Sponsors & Collaborators

  • The Leeds Teaching Hospitals NHS Trust

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • Chiesi UK

    lead INDUSTRY

Principal Investigators

  • Kevin Goss, MBBS · Leeds Teaching Hospitals NHS Trust

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-26
Primary Completion
2024-03-30
Completion
2024-03-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03808402 on ClinicalTrials.gov